What Grow Pharma does

Grow Pharma OOD is a privately held Bulgarian pharmaceutical company headquartered in Sofia that develops and sells medical cosmetics and dietary supplements through its own e-commerce platform (growpharma.bg) and the Bulgarian pharmacy network. The company's portfolio centers on enzymatic formulations based on subtilisin protease, developed in collaboration with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences (BAS). Its four commercial products are NEPROLYZIN G (a proteolytic enzyme gel containing subtilisin 250 CTA units per gram with chlorhexidine digluconate for cleaning purulent and necrotic wounds), POST-NEPROL (an epithelializing gel with subtilisin 200 CTA units, hydrolyzed collagen, D-panthenol, and vitamins A and E for skin and mucous membrane regeneration), TONSILIC syrup (a 200 ml immune and throat-support supplement containing beta-glucan, L-arginine, iodine, and B-complex vitamins), and Creatine STRNG (a buffered creatine supplement at pH 7.5 designed to resist stomach acid breakdown for two hours).

Name

Grow Pharma

Legal name

Гроу Фарма ООД

Website

https://growpharma.bg

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Grow Pharma OOD is a Sofia-based Bulgarian pharmaceutical company that develops and sells medical cosmetics and dietary supplements based on proprietary subtilisin protease and buffered creatine formulations, distributing through its own e-commerce platform and the Bulgarian pharmacy network.

Ownership category

akta.pro rank

Product category

Pharmaceutical & Dietary Supplements

NAICS

Medicinal and Botanical Manufacturing (325411), Soap and Cleaning Compound Manufacturing (32561), Food (Health) Supplement Retailers (456191)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industry

Herbal & Botanical Supplements (CRADAGAD)

Keywords

• Medical cosmetics
• Dietary supplements
• Enzymatic wound care
• Subtilisin protease gels
• Nutritional supplements

Headquarters

HQ city

Sofia

HQ country

Bulgaria

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Product sales (e-commerce and pharmacy): Grow Pharma generates revenue through direct sales of medical cosmetics and nutritional supplements via its own online store (growpharma.bg) and through the Bulgarian pharmacy network (аптечната мрежа). Products are sold as one-time purchases at fixed retail prices.
2. Medical cosmetics (topical pharmaceutical gels): Revenue from medical-grade topical gels (НЕПРОЛИЗИН Г and ПОСТ-НЕПРОЛ) sold at unit prices ranging from 9 to 31 лв. These products are distributed both online and through pharmacies.
3. Nutritional supplements (liquid and powder): Revenue from dietary supplements including TONSILIC syrup (25 лв per 200ml) and Creatine STRNG (29 лв per pack). Sold through e-commerce and pharmacy network.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Grow Pharma develops and sells proprietary medical cosmetics (NEPROLYZIN G and POST-NEPROL enzymatic wound-care gels based on subtilisin protease) and dietary supplements (TONSILIC immune-support syrup and Creatine STRNG buffered creatine). All products are formulated in collaboration with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences and sold to individual consumers through the company's own e-commerce platform and the Bulgarian pharmacy network.

Product overview

Grow Pharma offers a focused portfolio of medical cosmetics and dietary supplements developed in Bulgaria. The medical cosmetics line includes POST-NEPROL (epithelializing gel for skin/mucous membrane regeneration) and NEPROLYZIN G (proteolytic enzyme gel for wound cleaning), both based on subtilisin enzyme technology. The dietary supplements include TONSILIC syrup (immune and throat health support with vitamins and beta-glucan) and Creatine STRNG (buffered creatine for sports performance). All products are developed in collaboration with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences.

Differentiator

Problem solved

Functional benefit

Products and services

• NEPROLYZIN G (НЕПРОЛИЗИН Г) enzymatic wound-cleaning gel Medical-cosmetic proteolytic-enzyme gel for cleaning hard-to-heal purulent and necrotic wounds. Contains subtilisin (250 CTA units/g), glycerol, and chlorhexidine digluconate. Selectively degrades peptide bonds in necrotic tissue without affecting healthy cells. Sold in 20g and 50g sizes and bundle packs (Gx2, Gx4). For patients and clinicians treating gangrene, diabetic foot, burns, pressure ulcers (decubitus), and post-surgical wounds.
• POST-NEPROL (ПОСТ-НЕПРОЛ) epithelializing gel Medical-cosmetic epithelializing gel with proteolytic enzyme (subtilisin 200 CTA units) for skin and mucous-membrane regeneration, hydration and softening. Contains partially hydrolyzed sterile collagen (5%), D-Panthenol (2%), Vitamin A (15,000 IU), Vitamin E (10mg), zinc oxide, magnesium oxide, glycerol, and chlorhexidine digluconate. Available in 20g and 50g sizes. For post-wound skin regeneration and mucous-membrane care.
• TONSILIC (ТОНЗИЛИК) immune-support syrup 200ml 200ml dietary-supplement syrup for throat and immune support, formulated with beta-glucan, L-arginine, iodine, B-complex vitamins (B2, B3, B5, B6, B9), vitamin C, and niacins. Dosing: 5ml once daily on empty stomach for children up to 6 years; 10ml once daily on empty stomach for children over 6 and adults. Targets children with underdeveloped immunity and frequent upper respiratory infections, and adults with recurrent tonsillar/throat issues.
• Creatine STRNG buffered creatine supplement Innovative buffered creatine dietary supplement with a pH 7.5 phosphate buffer developed with the Institute of Organic Chemistry at BAS. Packaged as 5g sachets (14 sachets per package). Recommended dose: 2 sachets (10g) daily dissolved in 200–300ml warm water, waiting 5–6 minutes before consumption. Designed for athletes and fitness consumers seeking maximum creatine absorption without loading phase or kidney strain.

Quantifiable outcome

• Neprolysin has been used successfully in major Bulgarian hospitals including Pirogov, Alexandrovска, and the Military Medical Academy, saving many patients from amputation
• +3 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Institute of Organic Chemistry at the Bulgarian Academy of Sciences (БАН)coreStrategic or Co-development PartnerGrow Pharma collaborates with the Institute of Organic Chemistry at the Bulgarian Academy of Sciences (БАН) for product development. Prof. Peter Nedkov and his team from the institute developed the Neprolysin and Post-Neprol enzymatic formulations. The buffered creatine Creatine STRNG was also created with the institute's scientific support. This partnership provides the scientific foundation for Grow Pharma's proprietary pharmaceutical and nutritional products.
• Bulgarian Hospitals (Pirogov, Alexandrovска, Military Medical Academy)coreOthersNeprolysin has been used successfully in major Bulgarian hospitals including Pirogov, Alexandrovска Hospital, and the Military Medical Academy (ВМА). These institutions serve as clinical validation sites for the product's efficacy in treating gangrene and hard-to-heal wounds, with documented cases of saving patients from amputation.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Myprotein: Leading global sports nutrition brand owned by THG. Competes in creatine monohydrate and sports supplements via direct-to-consumer e-commerce, with significantly larger marketing scale and broader product portfolio than Grow Pharma's single-SKU creatine line.
• Coloplast: Danish multinational with a wound and skin care division addressing pressure ulcers, diabetic foot, and post-surgical wounds. Comparable in wound-care therapeutic focus but with substantially larger R&D, regulatory, and distribution resources.
• Medline Industries: Privately held global medical supply manufacturer and distributor with wound-care, surgical, and skin-care categories. Competes broadly in wound management and skin regeneration, with scale and hospital-supply contracts that dwarf Grow Pharma's footprint.
• ConvaTec Group: Global medical products company specializing in advanced wound care, ostomy, and continence care. Directly competes in the chronic-wound management space served by Neprolysin G, with established hospital and home-care channels across multiple geographies.
• Mölnlycke Health Care: Global leader in wound care and surgical solutions. Competes in the same wound-care category (necrotic/ulcer management) with hospital-channel distribution, but operates at significantly greater scale with broader portfolios across dressings, antiseptics, and OR solutions.
• Smith & Nephew: Multinational medical device company with a sizable Advanced Wound Management division. Comparable in addressing chronic wounds, burns, and diabetic foot ulcers, but with global scale, extensive clinical-trial data, and diversified product lines beyond Grow Pharma's focused enzymatic gel portfolio.

Direct peers

• Sopharma AD: Bulgaria's largest pharmaceutical manufacturer, also headquartered in Sofia. Directly comparable as a Bulgarian pharma company producing and distributing medicinal and consumer health products domestically, including through pharmacy networks, with similar regulatory exposure to Bulgarian and EU frameworks.
• Olimp Labs: Polish sports nutrition brand specializing in creatine, protein, and performance supplements. Directly competes in the creatine category targeted by Creatine STRNG, with comparable mass-market pricing strategy and pharmacy/online distribution in CEE markets.
• Tchaikapharma: Bulgarian pharmaceutical company focused on generics and consumer health products. Operates in the same domestic market with overlapping pharmacy distribution and similar regulatory positioning under Bulgarian and EU pharmaceutical frameworks.

Regional players

• Abela Pharma: Regional pharmaceutical distributor and consumer health brand in the Western Balkans. Comparable as a smaller-scale CEE pharma company distributing through pharmacy channels, though focused on distribution rather than proprietary formulation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/growpharma.bg
• LinkedInlinkedin.com/company/grow-pharma

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Grow Pharma